Domenico Memoli

Baronissi, 84081, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Correction: Suppression of Spry1 reduces HIF1α‑dependent glycolysis and impairs angiogenesis in BRAF‑mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 21, 2026

Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study.

Epigenetic alterations of AKT1 orchestrate a metabolic reprogramming in advanced lipedema: translational insights from an integrated multi-omics study.

Journal: Journal of translational medicine

Published: November 03, 2025

Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin.

Identification of LncRNAs scaffolding a chromatin-associated gene regulatory complex in breast cancer cells comprising ERα, DOT1L and menin.

Journal: Cell communication and signaling : CCS

Published: September 03, 2025

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Castalin Induces ROS Production, Leading to DNA Damage and Increasing the Activity of CHK1 Inhibitor in Cancer Cell Lines.

Journal: Antioxidants (Basel, Switzerland)

Published: August 03, 2025

Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.

Non-coding RNA profiling in BRAFV600E-mutant cutaneous melanoma before and after Spry1 depletion.

Journal: Scientific data

Published: June 13, 2025

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.

Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies.

Journal: Journal of translational medicine

Published: June 10, 2025

Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer.

Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer.

Journal: Cell death & disease

Published: April 27, 2025

Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6.

Praja2 controls P-body assembly and translation in glioblastoma by non-proteolytic ubiquitylation of DDX6.

Journal: EMBO reports

Published: October 08, 2024

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Suppression of Spry1 reduces HIF1α-dependent glycolysis and impairs angiogenesis in BRAF-mutant cutaneous melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: September 02, 2024

Small non-coding RNA transcriptomic profiling in adult and fetal human brain.

Small non-coding RNA transcriptomic profiling in adult and fetal human brain.

Journal: Scientific data

Published: March 04, 2024

Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation.

Expression of targets of the RNA-binding protein AUF-1 in human airway epithelium indicates its role in cellular senescence and inflammation.

Journal: Frontiers in immunology

Published: March 22, 2023

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer.

Combinatorial targeting of menin and the histone methyltransferase DOT1L as a novel therapeutic strategy for treatment of chemotherapy-resistant ovarian cancer.

Journal: Cancer cell international

Published: June 13, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026